Novartis Commits up to $2.2B Toward Developing Arrowhead siRNA Therapy
@Novartis
agreed to license and develop
@ArrowheadPharma
’s preclinical stage siRNA therapy ARO-SNCA, a potential treatment for #Parkinsonsdisease and other synucleinopathies

Model-directed generative design is applied to CRISPR–Cas13a guide RNAs, outperforming natural sequences go.nature.com/4dLvhQf
rdcu.be/eADRm

Considering the enormous human and economic toll Chagas disease inflicts, investment in R&D of medical innovations such as diagnostics, pharmaceuticals and vaccines remains disproportionately low go.nature.com/4lqNXZ6
rdcu.be/eALyf

Had the most amazing time with my best friends, memories we’ll never forget! Life is so much better with them by my side. Cheers to unforgettable moments and endless laughter! #BestFriendsForever #UnforgettableMemories #GreatTimes #LifeIsGood

Biotech news from around the world: Slovenia, Rwanda, Saudi Arabia, Denmark nature.com/articles/s41...
rdcu.be/eDKHb

🌙 Over 2,200 visitors, 250+ volunteers, and one unforgettable Science Night at the CMCB,
@tudresden.bsky.social
!

Huge thanks to everyone who joined us – and to our amazing volunteers!

#LNDWDD #Dresden #CMCBnews

Leveraging machine learning and big data techniques to map the global patent landscape of phage therapy go.nature.com/4iIFelb